Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Microarray and proteomics expression profiling identifies several candidates, including the valosin-containing protein (VCP), involved in regulating high cellular growth rate in production CHO cell lines.
Doolan P, Meleady P, Barron N, Henry M, Gallagher R, Gammell P, Melville M, Sinacore M, McCarthy K, Leonard M, Charlebois T, Clynes M. Doolan P, et al. Among authors: charlebois t. Biotechnol Bioeng. 2010 May 1;106(1):42-56. doi: 10.1002/bit.22670. Biotechnol Bioeng. 2010. PMID: 20091739
CHO DUKX cell lineages preadapted to growth in serum-free suspension culture enable rapid development of cell culture processes for the manufacture of recombinant proteins.
Sinacore MS, Charlebois TS, Harrison S, Brennan S, Richards T, Hamilton M, Scott S, Brodeur S, Oakes P, Leonard M, Switzer M, Anagnostopoulos A, Foster B, Harris A, Jankowski M, Bond M, Martin S, Adamson SR. Sinacore MS, et al. Among authors: charlebois ts. Biotechnol Bioeng. 1996 Nov 20;52(4):518-28. doi: 10.1002/(SICI)1097-0290(19961120)52:4<518::AID-BIT7>3.0.CO;2-S. Biotechnol Bioeng. 1996. PMID: 18629924
The manufacturing process for B-domain deleted recombinant factor VIII.
Eriksson RK, Fenge C, Lindner-Olsson E, Ljungqvist C, Rosenquist J, Smeds AL, östlin A, Charlebois T, Leonard M, Kelley BD, Ljungqvist A. Eriksson RK, et al. Among authors: charlebois t. Semin Hematol. 2001 Apr;38(2 Suppl 4):24-31. doi: 10.1016/s0037-1963(01)90105-2. Semin Hematol. 2001. PMID: 11449332 Review.
The manufacturing process for recombinant factor IX.
Harrison S, Adamson S, Bonam D, Brodeur S, Charlebois T, Clancy B, Costigan R, Drapeau D, Hamilton M, Hanley K, Kelley B, Knight A, Leonard M, McCarthy M, Oakes P, Sterl K, Switzer M, Walsh R, Foster W. Harrison S, et al. Among authors: charlebois t. Semin Hematol. 1998 Apr;35(2 Suppl 2):4-10. Semin Hematol. 1998. PMID: 9565160 Review.
Viral safety of recombinant factor IX.
Adamson S, Charlebois T, O'Connell B, Foster W. Adamson S, et al. Among authors: charlebois t. Semin Hematol. 1998 Apr;35(2 Suppl 2):22-7. Semin Hematol. 1998. PMID: 9565163
Viral safety of B-domain deleted recombinant factor VIII.
Charlebois TS, O'connell BD, Adamson SR, Brink-Nilsson H, Jernberg M, Eriksson B, Kelley BD. Charlebois TS, et al. Semin Hematol. 2001 Apr;38(2 Suppl 4):32-9. doi: 10.1016/s0037-1963(01)90106-4. Semin Hematol. 2001. PMID: 11449333 Review.
18 results